Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,517 | -7,056 | -4,290 | -2,261 | -5,687 |
| Depreciation Amortization | 101 | 73 | 46 | 23 | 34 |
| Accounts payable and accrued liabilities | 126 | -233 | -261 | 1,092 | 647 |
| Other Working Capital | 537 | -2 | -376 | 1,350 | 1,349 |
| Other Operating Activity | -27 | 233 | 261 | -1,092 | 56 |
| Operating Cash Flow | $-8,780 | $-6,986 | $-4,620 | $-888 | $-3,601 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -65 | 1 | -1 | -275 |
| Investing Cash Flow | $-130 | $-65 | $1 | $-1 | $-275 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 5 | N/A | N/A | 4,500 |
| Other Financing Activity | 16,760 | 16,760 | 16,760 | 0 | 0 |
| Financing Cash Flow | $16,764 | $16,764 | $16,760 | $N/A | $4,500 |
| Beginning Cash Position | 1,027 | 1,027 | 1,027 | 1,027 | 402 |
| End Cash Position | 8,881 | 10,741 | 13,168 | 137 | 1,027 |
| Net Cash Flow | $7,854 | $9,714 | $12,141 | $-889 | $624 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,780 | -6,986 | -4,620 | -888 | -3,601 |
| Capital Expenditure | -130 | -65 | 1 | -1 | -275 |
| Free Cash Flow | -8,910 | -7,050 | -4,619 | -889 | -3,876 |